Selank

Selank is a synthetic heptapeptide developed in Russia during the 1980s as part of research into immune-modulating compounds. Originally derived from tuftsin, a naturally occurring tetrapeptide that regulates immune function, Selank was engineered with additional amino acids to enhance stability and cross the blood-brain barrier more effectively [1]. The peptide gained attention in Russian medical research for its dual effects on both immune function and neurological processes.\n\nUnlike traditional anxiolytics that work through GABA receptors, Selank operates through a completely different mechanism involving neurotrophic factors and monoamine regulation. This has made it a research interest for those seeking anxiety relief without the sedation, cognitive impairment, or dependency risks associated with benzodiazepines [2]. In Russia, it's been used clinically since the early 2000s, though it remains largely experimental in Western contexts.\n\nToday, Selank is primarily used by researchers and biohackers interested in its reported effects on stress resilience and cognitive function. Users typically report a subtle but noticeable reduction in background anxiety and improved mental clarity, particularly during periods of high stress or cognitive demand.